Reference
Milliman Inc. The Impact of New Hepatitis C Drug Therapy on Individual Medicare Part D Spending. Internet Document : 2 Aug 2014. Available from: URL: http://www.pcmanet.org/images/stories/uploads/2014/partdpremiumstudymilliman.pdf
Rights and permissions
About this article
Cite this article
New HCV drugs set to inflate US Medicare Part D spending. PharmacoEcon Outcomes News 709, 10 (2014). https://doi.org/10.1007/s40274-014-1469-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1469-8